Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

T-440: a new antiasthma drug candidate from Tanabe

Feb. 26, 1998

Animal study indicates efficacy of oral PAF antagonist in allergic rhinitis

Feb. 26, 1998

TRH ineffective as treatment for lung problems in premature infants

Feb. 25, 1998

First corticosteroid dry powder inhaler launched in the U.S.

Feb. 24, 1998

Evaluation of anti-IgE therapy in patients with seasonal allergic rhinitis

Feb. 24, 1998

TAU-284 awaiting approval in Japan

Feb. 23, 1998

Role of nonsteroidal antiinflammatory therapy in asthma

Feb. 20, 1998

Lisofylline enters pivotal testing for acute lung injury

Feb. 20, 1998

Independent evaluation committee requests additional OxSODrol data

Feb. 20, 1998

Enrollment complete in phase II trials for rPAF-AH

Feb. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...